Analyst: Pharma a safe haven; Neoprobe shareholders approve sale of radiation detector biz;

@FiercePharma: J&J chief gets chance to advise Obama on job creation. How about this: Avoid recalls, Mr. President. Article | Follow @FiercePharma

> A Jefferies & Co. analyst says pharma stocks will become a defensive sector for investors despite such challenges as patent expirations. Story

> Neoprobe shareholders have approved the company's deal to sell its chief source of revenue as the company bets on drug development. Report

> A new sub-analysis of a set of patients from the TRITON-TIMI 38 study showed that treatment with prasugrel in combination with aspirin was associated with a 26% relative risk reduction in the combined primary endpoint of cardiovascular death, myocardial infarction or stroke, compared with treatment with clopidogrel. Eli Lilly release

> Foster City officials are excited by the prospects of Gilead Sciences expanding its facilities, and say they have a plan to keep down traffic. News 

> West Pharmaceutical Services will expand its R&D center in St. Petersburg, FL. West's advanced development center will focus on new elastomer formulations, process technologies and products for its global component manufacturing network. West release

Biotech News

@FierceBiotech: MA-based Proteon Therapeutics has raised $15.2M in an equity and options financing. Item | Follow @FierceBiotech

@JohnCFierce: Generic drug makers agree to program in which they pay an initial $299M to speed up FDA reviews, clear a backlog. Story | Follow @JohnCFierce

Sign up for our FREE newsletter for more news like this sent to your inbox!

@RyanMFierce: Broad Institute CIO says genome research outfit on way to filling 10-petabyte capacity. Interview | Follow @RyanMFierce

@MaureenFierce: Study: Illegal online pharmacies are manipulating Internet searches to send consumers to their sites. Report | Follow @MaureenFierce

> Analysts see an upside after market swings bludgeon biotechs. Story

> Acorda CEO Cohen throws his weight behind new biotech trailblazer. Report

> Embera adds $4.5 million in Series A cash. News

> Pulmatrix reels in $14M for its work on COPD, cystic fibrosis. Story

Biotech IT News

> Accelyrs' revenue Q2 up 86% after mergers. Report

> New CIO reach tackles IT needs at the Broad Institute. More

> Virtual rats in the works to aid disease research. Details

> Perceptive Informatics does part in Parexel's losing Q4. Story

> BMS taps GNS Healthcare for computer model of information. News

> Medidata sees CFO resign after Q2 growth. Article

Medical Device News

> Device industy sees more investment, fewer deals. Details

> Sen. Brown visits Covidien, lobbies against device tax. News

> Southern Diagnostic Laboratories bought by Solstas. Story

> NEJM authors come out in support of IOM report. Article

And Finally... MIT researchers say they've designed a drug that could potentially cure the common cold, flu and even Ebola. Item

Suggested Articles

BMS' Opdivo-Yervoy combo is playing in an increasingly crowded space. But the company is leaning on new long-term data to set its regimen apart.

GSK and Alcon have pulled off prescription-to-OTC switches in hopes of giving aging brands Voltaren and Pataday a boost.

Sanofi didn't hesitate to enter Zika vaccine R&D, and despite the associated scandal, the company is again jumping into emerging disease vaccine R…